Total Payments
$129,996
2024 Payments
$8,249
Companies
41
Transactions
568
Medicare Patients
3,316
Medicare Billing
$328,055
Payment Breakdown by Category
Other$88,951 (68.4%)
Consulting$24,050 (18.5%)
Food & Beverage$10,984 (8.4%)
Travel$5,454 (4.2%)
Education$556.73 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $88,951 | 47 | 68.4% |
| Consulting Fee | $24,050 | 23 | 18.5% |
| Food and Beverage | $10,984 | 464 | 8.4% |
| Travel and Lodging | $5,454 | 21 | 4.2% |
| Education | $556.73 | 13 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $121,672 | 138 | $0 (2024) |
| Astellas Pharma US Inc | $1,813 | 89 | $0 (2024) |
| Janssen Biotech, Inc. | $1,631 | 141 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $640.14 | 6 | $0 (2024) |
| ABBVIE INC. | $446.50 | 21 | $0 (2024) |
| PFIZER INC. | $432.88 | 25 | $0 (2024) |
| FUJIFILM Medical Systems USA, Inc. | $359.30 | 3 | $0 (2018) |
| TOLMAR Pharmaceuticals, Inc. | $342.75 | 16 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $272.12 | 16 | $0 (2022) |
| Verity Pharmaceuticals Inc. | $232.11 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,249 | 66 | Boston Scientific Corporation ($7,286) |
| 2023 | $11,362 | 84 | Boston Scientific Corporation ($10,241) |
| 2022 | $18,205 | 86 | BOSTON SCIENTIFIC CORPORATION ($17,127) |
| 2021 | $8,153 | 81 | BOSTON SCIENTIFIC CORPORATION ($6,951) |
| 2020 | $25,415 | 39 | Boston Scientific Corporation ($25,047) |
| 2019 | $6,718 | 63 | Boston Scientific Corporation ($5,834) |
| 2018 | $30,825 | 72 | Boston Scientific Corporation ($29,358) |
| 2017 | $21,069 | 77 | BOSTON SCIENTIFIC CORPORATION ($19,827) |
All Payment Transactions
568 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: HORMONE THERAPY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Oncology | ||||||
| 10/30/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,995.00 | General |
| Category: GreenLight_URO | ||||||
| 10/24/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: GreenLight_URO | ||||||
| 10/24/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $475.00 | General |
| Category: GreenLight_URO | ||||||
| 10/18/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: UROLOGY | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,187.50 | General |
| Category: GreenLight_URO | ||||||
| 10/03/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: GreenLight_URO | ||||||
| 10/02/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: GreenLight_URO | ||||||
| 09/30/2024 | Boston Scientific Corporation | GreenLight XPS (Device) | Food and Beverage | In-kind items and services | $133.81 | General |
| Category: GreenLight_URO | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $27.24 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $25.19 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 08/19/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: UROLOGY | ||||||
| 08/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 830 | 1,081 | $178,870 | $68,930 |
| 2022 | 16 | 878 | 1,248 | $223,113 | $91,530 |
| 2021 | 12 | 780 | 1,101 | $213,435 | $86,808 |
| 2020 | 12 | 828 | 1,164 | $223,280 | $80,786 |
Total Patients
3,316
Total Services
4,594
Medicare Billing
$328,055
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 195 | $29,300 | $14,029 | 47.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 68 | 70 | $31,600 | $14,010 | 44.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $28,200 | $12,206 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 107 | $21,500 | $10,183 | 47.4% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $33,000 | $6,652 | 20.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $6,950 | $3,404 | 49.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 26 | 26 | $6,500 | $2,776 | 42.7% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 25 | 26 | $7,800 | $2,246 | 28.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 209 | 374 | $5,610 | $1,275 | 22.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 11 | $2,200 | $1,118 | 50.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 67 | 75 | $5,175 | $880.50 | 17.0% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 67 | 69 | $1,035 | $151.06 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 137 | 260 | $39,200 | $19,770 | 50.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 118 | 118 | $35,700 | $16,400 | 45.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 73 | 74 | $33,400 | $15,614 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 106 | $21,250 | $11,069 | 52.1% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2022 | 11 | 11 | $33,000 | $6,800 | 20.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 29 | $8,700 | $4,432 | 50.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 35 | 36 | $9,050 | $4,223 | 46.7% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2022 | 11 | 11 | $7,150 | $3,459 | 48.4% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 33 | 33 | $9,950 | $2,986 | 30.0% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 13 | 13 | $8,000 | $2,526 | 31.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 234 | 471 | $7,065 | $1,619 | 22.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 17 | 18 | $3,600 | $1,578 | 43.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 13 | 13 | $4,650 | $649.56 | 14.0% |
About Dr. David Robbins, MD
Dr. David Robbins, MD is a Urology healthcare provider based in North Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1588848683.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Robbins, MD has received a total of $129,996 in payments from pharmaceutical and medical device companies, with $8,249 received in 2024. These payments were reported across 568 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($88,951).
As a Medicare-enrolled provider, Robbins has provided services to 3,316 Medicare beneficiaries, totaling 4,594 services with total Medicare billing of $328,055. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location North Miami, FL
- Active Since 12/26/2007
- Last Updated 05/05/2015
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588848683
Products in Payments
- GREENLIGHT (Device) $47,230
- GreenLight XPS (Device) $21,145
- GENERAL - BPH (Device) $15,332
- REZUM (Device) $15,247
- General - Vascular Access (Device) $6,520
- GREENLIGHT XPS (Device) $4,595
- General - BPH (Device) $3,900
- GENERAL THERAPIES (Device) $1,557
- GENERAL THERAPIES (Device) $1,522
- ERLEADA (Drug) $1,224
- XTANDI (Drug) $1,064
- rezum Generator (Device) $1,000
- GENERAL BPH (Device) $875.00
- Myrbetriq (Drug) $647.07
- Rezum Generator (Device) $604.21
- ELIGARD (Drug) $391.32
- Erleada (Drug) $322.86
- MYRBETRIQ (Drug) $295.89
- AQUABEAM ROBOTIC SYSTEM (Device) $293.54
- THERAPIES (Device) $290.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.